National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody G250
A chimeric monoclonal antibody directed against G250, a cell surface antigen found in the majority of renal cell carcinomas. Following binding, monoclonal antibody G250 (mAb G250) may be internalized by G250 antigen-expressing renal carcinoma cells; mAb G250 may be useful as a carrier for radioisotopes and other antineoplastic therapeutic agents. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:chimeric monoclonal antibody cG250
WX-G250
US brand name:Rencarex
Abbreviations:cG250
MOAB G250



Previous:monoclonal antibody CAL, monoclonal antibody CC49, monoclonal antibody CC49-delta CH2, monoclonal antibody Ch14.18, monoclonal antibody E2.3
Next:monoclonal antibody GD2 anti-idiotype vaccine, monoclonal antibody hA20, monoclonal antibody HeFi-1, monoclonal antibody hLL1, monoclonal antibody Hu3S193

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov